Biogen

News

NHS saving £300m with Humira biosimilar deal

The NHS is to save £300 million after striking deals with several manufacturers of low cost biosimilars of AbbVie’s Humira inflammatory diseases drug.

News

Merck KGaA's BTK drug reduces lesions in relapsing MS patien...

Germany’s Merck KGaA has said it is “encouraged” by mid-stage trial results showing that its Bruton’s kinase (BTK) class drug evobrutinib reduced occurrence of central nervous system lesion

News

NICE in talks with Biogen after rejecting SMA drug

NICE wants 'managed access' scheme

News

Closeup of X-ray photography of human brain

Biogen and Eisai Alzheimer's drug excites doctors, but not i...

Investors spooked after string of failures

News

PureTech to research Alzheimer's drugs based on 'brain drain...

US biotech PureTech Health is to develop therapies that are based on a new theory that neurological diseases such as Alzheimer’s are linked to drainage issues in the brain.

News

AbbVie's Orilissa gets FDA nod as Humira competition looms

AbbVie needs new drugs as its mega-blockbuster Humira won’t bring in billions forever – and after the embarrassing withdrawal of an MS drug earlier this year it has managed to get a substan

NHS saving £300m with Humira biosimilar deal

Merck KGaA's BTK drug reduces lesions in relapsing MS patien...

NICE in talks with Biogen after rejecting SMA drug

Biogen and Eisai Alzheimer's drug excites doctors, but not i...

PureTech to research Alzheimer's drugs based on 'brain drain...

AbbVie's Orilissa gets FDA nod as Humira competition looms

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Biogen

Editor's Picks